Satellos Bioscience Inc.: Satellos Bioscience Announces Q3 2022 Financial Results and Operational Highlights
Toronto, Ontario--(Newsfile Corp. - November 23, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a drug discovery company developing therapeutics to regenerate muscle
Source: finanznachrichten.de